Skip to main content
Log in

Pharmacologic manipulation of the ductus arteriosus in the neonate : a physiologic basis and current state of the art

  • Symposium: Pediatric Cardiology
  • Published:
The Indian Journal of Pediatrics Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Olley PM, Coceani F, Bodach E. E-type prostaglandins: A new emergency therapy for certain cyanotic congenital heart malformations.Circulation 1976;53 : 728–731

    PubMed  CAS  Google Scholar 

  2. Heymann MA, Berman W., Rudolph AM, Whitman V. Dilatation of the ductus arteriosus by prostaglandin E in aortic arch abnormalities.Circulation 1979;59: 169–173

    PubMed  CAS  Google Scholar 

  3. Lewis AB, Freed MD, Heymann MA, Roehl SL, Kensey RC. Side-effect of therapy with prostaglandin E in infants with critical cyanotic heart disease.Circulation 1981;64: 893–898

    PubMed  CAS  Google Scholar 

  4. Gersony WM, Peckham GJ, Ellison RC, Miettinen OS, Nadas AS. Effects of indomethacin in premature infants with patent ductus arteriosus: Results of a national collaborative study.J Pediatr 1983;102 : 895–907

    Article  PubMed  CAS  Google Scholar 

  5. Mahony L, Caldwell RC, Girod DA. Indomethacin therapy on first day of life in infants with very low-birth-weight.J Pediatr 1985;106: 801–805

    Article  PubMed  CAS  Google Scholar 

  6. Gersony WM. Patent ductus arteriosus in the neonate.Ped Clin North Am 1986;33: 545–560

    CAS  Google Scholar 

  7. Congdon ED. Transformation of the aortic arch system during the development of the human embryo.Contributions to Embryology 1922;14: 65–70

    Google Scholar 

  8. Bruins CLD. De artercile pool van het hart. (Thesis) Leiden: Drukkerij, Groen en Zoon, 1977.

    Google Scholar 

  9. Anderson RH, Becker AE. In : slide Atlas of cardiac anatomy. 10. The development of the heart. Gower Medical Publishing Ltd 1980; pp 10, 20–10 21.

  10. Rudolph AM.The ductus arteriosus and persistent patency of the ductus arteriosus. In: congenital diseases of the heart. Chicago : Year Book Medical Publishers Inc., 168–201, 1980

    Google Scholar 

  11. Rudolph AM. The fetal circulation. In congenital diseases of the heart. Chicago: Year Book Medical Publishers, 1980 pp 1–6

    Google Scholar 

  12. Rudolph AM. Fetal and neonatal pulmonary circulation.Ann Rev Physiol 1979;41: 383–395

    Article  CAS  Google Scholar 

  13. Arcilla RA, Thidenius OG, Ranniger K. Congestive heart failure from suspected ductus closure in utero.J Pediatr 1969;75: 74–78

    Article  PubMed  CAS  Google Scholar 

  14. Coceani F, Olley PM. The response of the ductus arteriosus to prostaglandins.Canad J Physiol Pharmacol 1973;51: 220–225

    CAS  Google Scholar 

  15. Friedman WF, Moloney DA, Kirkpatrick SF. Prostaglandins: Physiologic and clinical correlations.Adv Pediatr 1978;25 : 173–194

    Google Scholar 

  16. Stuart MJ. Prostaglandins and homeostatis: An overview.Adv Ped 1983;30 : 321–364

    CAS  Google Scholar 

  17. Rudolph AM. Changes in circulation after birth. Congenital diseases of the heart. Chicago: Year Book Publisher, 1980 ; 17–28

    Google Scholar 

  18. Jager BV, Wollernman OJ. An anatomical study of the closure of the ductus arteriosus.Am J Pathol 1942;18: 595–601

    CAS  PubMed  Google Scholar 

  19. Kennedy JA, Clark SL. Observation on the physiological reaction of the ductus arteriosus.Am J Physiol 1962;136: 140–147

    Google Scholar 

  20. Kovalcik V. The response of the isolated ductus arteriosus to oxygen and anoxia.J Physiol 1963;169: 185–191

    PubMed  CAS  Google Scholar 

  21. Rudolph AM.Pre and post-natal pulmonary circulation in congenital diseases of the heart. Chicago: Year Book Publishers, 1980 pp 29–48

    Google Scholar 

  22. McMurphy DM, Heymann MA, Rudolph AM, Melmon KL. Developmental changes in the constriction of the ductus arteriosus: Responses to oxygen and vasoactive agents in the isolated ductus arteriosus of the fetal lamb.Pediatr Res 1972;6 : 231–238

    Article  PubMed  CAS  Google Scholar 

  23. Christie A. Normal closing time of foramen ovale and ductus arteriosus, anatomic and statistical study.AJDC 1930;40: 323–326

    Google Scholar 

  24. Gitternberger de Groot AC. Persistent ductus arteriosus: Most probably a primary congenital malformation.Br Heart J 1977;6 : 610–615

    Article  Google Scholar 

  25. Lev M. Pathologic anatomy and interrelationship of hypoplasia of the aortic tract complexes.Lab Invest 1952;1: 61–75

    PubMed  CAS  Google Scholar 

  26. Lev M, Arcilla R, Rimoldi HJA, Licata RH, Gasul BM. Premature narrowing or closure of the foramen ovale.Am Heart J 1963;65: 638–647

    Article  PubMed  CAS  Google Scholar 

  27. Harh JY, Paul MH, Gallen WJ, Friedberg DZ, Kaplan S. Experimental production of hypoplastic left heart syndrome in the chick embryo.Am J Cardiol 1973;31: 51–56

    Article  PubMed  CAS  Google Scholar 

  28. Davignon AL, Greenwold WE, Dushane JW, Edwards JE. Congenital pulmonary atresia with intact ventricular septum. Clinicopathological correlation of two anatomic types.Am Heart J 1961;62: 591–602

    Article  PubMed  CAS  Google Scholar 

  29. Heymann MA, Rudolph AM. Ductus arteriosus dilatation by prostaglandin E1 in infants with pulmonary atresia.Pediatrics 1977;59: 325–329

    PubMed  CAS  Google Scholar 

  30. Skoda. Quoted by Hochhaus: Veber Das Offenbleiben des Ductus Botalli.Dtsch Acc Kin Med 1893;51 : 1–10

    Google Scholar 

  31. Hutchins GM. Coarctation of the aorta explained as branch-point of the ductus arteriosus.Am J Pathol 1971;63: 203–209

    PubMed  CAS  Google Scholar 

  32. Elzenga NJ, Gittenberger de Groot AC. Localized coarctation of the aorta. Age Dependent spectrum.Br Heart J 1983;49: 317–325

    Article  PubMed  CAS  Google Scholar 

  33. Talner NS, Berman MA. Postnatal development of obstruction in coarctation of the aorta: Role of the ductus arteriosus.Pediatrics 1975;56 : 562–569

    PubMed  CAS  Google Scholar 

  34. Nudel DB, Gootman N. Clinical aspects of neonatal circulation. In: perinatal cardiovascular function. Gootman N and Gootman ed. New York, P.M. Marcel, Dekker Inc, 1983; pp 329–359

    Google Scholar 

  35. Nudel DB, Gootman N. Clinical of the neonate (Persistent fetal circulation syndrome).Adv Pediatr 1983;30: 61–91

    Google Scholar 

  36. Kitterman JA, Edmunds LM Jr, Gregory GA, Heymann MA, Tooley WM, Rudolph AM. Patent ductus arteriosus in premature infants: Incidence, relation to pulmonary disease and management.New Engl J Med 1972;284 : 473–481

    Article  Google Scholar 

  37. Dooley KJ. Management of the premature infant with a patent ductus arteriosus.Ped Clin North Am 1984;31: 1159–1174

    CAS  Google Scholar 

  38. Coceani F, Olley PM, Bodach E. Lamb ductus arteriosus. Effect of prostaglandin synthesis inhibitors on the muscle tone and the response to prostaglandin E1.Prostaglandins 1975;9: 299–308

    Article  PubMed  CAS  Google Scholar 

  39. Rao PS. Pediatric cardiology update. Recent therapeutic advances.Saudi Med J 1986;7: 306–320

    Google Scholar 

  40. Nutze RS, Starling MB, Elliot RB, Barrat-Boyes BG, Palliation of cyanotic congenital heart disease in infancy with E-type prostaglandins.Circulation 1977;55: 238–241

    Google Scholar 

  41. Lewis AB, Takahashi M, Lurie PR. Administration of prostaglandin E1 in neonates with critical congenital cardiac defects.J Pediatr 1978;93: 481–485

    Article  PubMed  CAS  Google Scholar 

  42. Zahka KG, Ronald JMA, Cutilletta AF, Gardner TJ, Donahoo JS, Kidd L. Management of aortic arch interruption with prostaglandin E1 infusion and microporous expanded polytetrafluoroethylene grafts.Am J Cardiol 1980;46: 1001–1005

    Article  PubMed  CAS  Google Scholar 

  43. Freed MD, Heymann MA, Lewis AB, Roechl SL, Kensey RC. Prostaglandin E1 in infants with ductus arteriosus dependent congenital heart disease.Circulation 1981 ;64: 899–905

    PubMed  CAS  Google Scholar 

  44. Silove ED, Coe JY, Shiu MF, Brunt JD, Pose AJF, Singh S, Mitchell MD. Oral prostaglandin E1 in ductus dependent pulmonary circulation.Circulation 1981 ;63: 682–688

    PubMed  CAS  Google Scholar 

  45. Cole RB, Abman S, Aziz KU, Bharati S, Lev M. Prolonged protaglandin E1 infusion: histologic effects on the patent ductus arteriosus.Pediatrics 1981;67: 816–819

    PubMed  CAS  Google Scholar 

  46. Gittenberger de-Groot AC, Moulaert AS, Harinck E, Becker AE. Histopathologic of the ductur arteriosus after prostaglandin E1 administration in ductus dependent cardiac anomalies.Br Heart J 1978;40: 215–218

    Article  Google Scholar 

  47. Haworth SG, Saver U, Biihlmeyer K. Effect of PGE on pulmonary circulation in pulmonary atresia. A quantitative morphometric study.Br Heart J 1980;43: 306–314

    Article  PubMed  CAS  Google Scholar 

  48. Ueda K, Saito A, Nakano H, Aoshima M, Yokota M, Muraoka R, Iwaya T. Cortical hyperostosis following long-term administration of prostaglandin E1 in infants with cyanotic congenital heart disease.J Pediatr 1981;97: 834–836

    Google Scholar 

  49. Kugler J, Nihill M, McNamara D. The association of infection and prostaglandin E1 in infants with cyanotic congenital heart disease. Abstract presented at the Southwest Pediatric Cardiology Society in Savannah, Georgia, U.S.A.; September 27, 1978

  50. Heymann MA, Rudolph AM, Silverman HH. Closure of the ductus arteriosus in premature infants by inhibition of prostaglandin synthesis.New Engl J Med 1976;295: 530–533

    Article  PubMed  CAS  Google Scholar 

  51. Friedman WF, Hirchklan MJ, Printz MP, Pitlick PT, Kirkpatrick SE. Pharmacologic closure of the ductus arteriosus in the premature infant.New Engl J Med 1976;295: 526–529

    Article  PubMed  CAS  Google Scholar 

  52. Yanagi RM, Wilson A, Newfeld EA, Aziz KU, Hunt CE. Indomethacin treatment for symptomatic patent ductus arteriosus: A double-blind controlled study.Pediatrics 1981;67: 647–652

    PubMed  CAS  Google Scholar 

  53. Yeh TF, Luken JA, Thalji A, Raval D, Carr I, Pilders RS. Intravenous indomethacin therapy in premature infants with persistent ductus arteriosus—a double blind controlled study.J Pediatr 1981 ;98: 137–145

    Article  PubMed  CAS  Google Scholar 

  54. Mahony L, Carnero V, Brett C, Heymann MA, Clyman RL. Prophylactic indomethacin therapy for very low birth weight infants.New Engl J Med 1982;306: 510–514

    Article  Google Scholar 

  55. Bhat R, Fischer R, Raju TNK, Vidyasagar D. Patent ductus arteriosus: Recent advances in diagnosis and management.Pediatr Clin North Am 1982;29 : 1117–1136

    PubMed  CAS  Google Scholar 

  56. Yeh TF, Wilks A, Singh J et al. Furosemide prevents the renal side effects of indomethacin therapy in preterm infants with patent ductus arteriosus.J Pediatr 1982;101: 433–437

    Article  PubMed  CAS  Google Scholar 

  57. Koren G, Zarfin Y, Pertman M, MacLeod SM. Effects of indomethacin on digoxin pharmacokinetics in preterm infants.Pediatr Pharmacol 1984;4: 25–30

    CAS  Google Scholar 

  58. Sanyal SK. Congenital heart disease in the newborn : Physiology diagnosis and management. In : Text Book of Neonatology. D.P. Vidyasagar ed. (in press).

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sanyal, S.K., Abu-Melha, A. Pharmacologic manipulation of the ductus arteriosus in the neonate : a physiologic basis and current state of the art. Indian J Pediatr 55, 35–50 (1988). https://doi.org/10.1007/BF02722558

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02722558

Keywords

Navigation